NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
David J. Adelstein(Cleveland Clinic), Susan Darlow(National Comprehensive Cancer Network), David G. Pfister(Memorial Sloan Kettering Cancer Center), Matthew E. Witek(University of Wisconsin Carbone Cancer Center), Frank Worden(University of Michigan), Antonio Jimeno(University of Colorado Cancer Center), Ellie Maghami(City Of Hope National Medical Center), Debra S. Leizman(Cleveland Clinic), Moon J. Fenton(University of Tennessee Health Science Center), James W. Rocco(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Barbara Burtness(Yale University), Jennifer L. Burns(National Comprehensive Cancer Network), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Ying J. Hitchcock(University of Utah), Sharon Spencer(University of Colorado Cancer Center), Loren K. Mell(University of California San Diego), Anthony J. Cmelak(Breast Cancer Research Foundation), David M. Brizel(Duke University), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Paul M. Busse(Massachusetts General Hospital), John A. Ridge(Fox Chase Cancer Center), Jimmy J. Caudell(Moffitt Cancer Center), Douglas R. Adkins(Washington University in St. Louis), A. Dimitrios Colevas(Cancer Institute (WIA)), Wesley L. Hicks, Maura L. Gillison(The University of Texas MD Anderson Cancer Center), Robert I. Haddad(Georgetown University), Sue S. Yom(University of California, San Francisco), Robert L. Foote(Mayo Clinic), William M. Lydiatt(Creighton University), Cristina P. Rodriguez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jill Gilbert(Cancer Clinic), Weining Zhen(Susan Thompson Buffett Foundation), Bharat B. Mittal(Northwestern University), Harlan A. Pinto(Cancer Institute (WIA)), David W. Eisele(Sidney Kimmel Comprehensive Cancer Center)
Cited by 378
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k